We’re excited to join Prague.bio! For us, this partnership opens new doors into the biotech community, not just in Czechia but across Europe. Prague.bio is deeply connected to the European ecosystem, whether through policy-making or networking, and that’s exactly what we need to scale #Floxgen into international markets. What once took bioinformaticians weeks, #Floxgen 🧬 can now handle in hours or days. ☝ The potential for AI driven gene analysis is huge, and being part of Prague.bio allows us to push these innovations even further. 🚀 Looking forward to new collaborations, knowledge sharing, and bringing biotech AI solutions to the next level!
We’re happy to introduce another member joining Prague.bio: DNAi! 🤩 What once took bioinformaticians several weeks of gene analysis can now be completed in just hours or days using Floxgen software, developed by DNAi 🧬 🖥️ The company, known for applying cutting-edge AI research and development in healthcare, manufacturing, and logistics, believes this software will save time typically spent on broad-spectrum approaches, reduce treatment costs, and ensure accurate and timely diagnoses for patients. As part of their R&D efforts, they are also creating a platform for digital twins 🧑🤝🧑 – virtual representations of physical systems, such as the human body, which simulate and predict real behaviors based on collected data. This technology is particularly valuable in healthcare for predicting potential diseases and recommending appropriate preventive treatments.